Altogether, our data show the elevation of liver E4BP4, especially hepatocyte E4BP4, in various mouse models of liver fibrosis in response to profibrogenic factors including TGF‐β and PDGF‐β through the ERK signaling pathway. The gene discussed is NFIL3; the disease is Hepatic fibrosis.